Testing effectiveness (Phase 2)UnknownNCT04356872
What this trial is testing
The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma
Who this might be right for
Sarcoma, Soft Tissue
Fudan University 45